EDIT
Editas Medicine, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.70
−0.74%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 23.77x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.94x
- Price / sales
- 8.82x
- Price / cash flow
- -3.46x
Enterprise value
- Enterprise value
- $218.5M
- EV / sales
- 4.65x
- EV / EBITDA
- -3.11x
- EV / EBIT
- -2.66x
- Market cap
- $414.7M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026